Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRAD study - Mineralocorticoid Receptor Antagonists in Type 2 Diabetes
2015-002519-14Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Eplerenone arm with Placebo arm (2 arms). Started Jun 2015; status: completed.
02
Drugs
eplerenone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-002519-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002519-14.